Pfizer Inc (NYSE:PFE)

43.79
Delayed Data
As of Sep 25
 -0.14 / -0.32%
Today’s Change
33.20
Today|||52-Week Range
44.46
+20.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line9.2B7.0B7.2B21.4B
 
 
 
 
 
Depreciation5.5B5.2B5.8B6.3B
 
 
 
 
 
Total Other Cash Flow489.0M1.8B3.5B-10.0B
 
 
 
 
 
Funds From Operations15.5B13.9B15.8B15.2B
 
 
 
 
 
Extraordinary Items-51.0M6.0M0.000.00
 
 
 
Funds From/For Other Operating Expenses-1.4B-564.0M-85.0M-1.3B
 
 
 
 
 
Net Cash Flow - Operating Activities16.9B14.5B15.9B16.5B
 
 
 
 
 
 
InvestingIncrease In Investments-61.7B-38.1B-28.2B-18.1B
 
 
 
 
 
Decrease In Investments57.4B52.8B40.7B16.0B
 
 
 
 
 
Capital Expenditures-1.2B-1.4B-1.8B-2.0B
 
 
 
 
 
Net Assets From Acquisitions -195.0M-16.5B-18.4B-1.0B
 
 
 
 
 
Other Investing - Uses---1.0M----
 
 
Other Investing - Sources347.0M344.0M52.0M650.0M
 
 
 
 
 
Net Cash Flow Investing-5.7B-3.0B-7.8B-4.7B
 
 
 
 
 
 
FinancingShort Term Borrowings-1.8B4.3B-714.0M-125.0M
 
 
 
 
 
Long Term Borrowings4.5B0.0011.0B5.3B
 
 
 
 
Long Term Debt Reduction-2.1B-3.0B-7.7B-6.2B
 
 
 
 
 
Net Proceeds Stock Sale1.0B1.3B1.0B862.0M
 
 
 
 
 
Common Preferred Redeemed-5.0B-6.2B-5.0B-5.0B
 
 
 
 
 
Common Dividends-6.6B-6.9B-7.3B-7.7B
 
 
 
 
 
Cash Dividends Paid - Total-6.6B-6.9B-7.3B-7.7B
 
 
 
 
 
Other Sources - Financing72.0M298.0M----
 
 
 
Other Uses - Financing----196.0M233.0M
 
 
 
Net Cash Flow - Financing-10.0B-10.2B-8.9B-13.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-83.0M-1.0B-215.0M53.0M
 
 
 
 
 
 
Net Change In Cash1.2B1.3B-831.0M-1.3B